# QENTOROS, LLC: Development of a nebulized peptide biologic to combat severe neutrophilic asthma

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | QENTOROS, LLC |
| Location | BLACKSBURG, VA |
| Project | Development of a nebulized peptide biologic to combat severe neutrophilic asthma |
| Project number | 1R41HL184794-01A1 |
| Mechanism | R41 |
| Institute | National Heart Lung and Blood Institute |
| Award | $305,800 |
| Awarded | 2026-09-04 |
| Project period | 2026-09-05 to 2028-08-31 |
| UEI | QM77G8E2BNL3 |

## Why this score
- Award of $305,800.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11409619). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.